NxWave | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

873 results for “NxWave”

Trials

View all 792 →

NEUWAVE Flexible Probe Study #2

First posted Oct 19, 2018

The Effect of Multimodal Approach of Electrotherapy Versus Shock Wave Therapy in Menopausal Women With Tennis Elbow.

45 participants · First posted Aug 6, 2026

The Effect of Laser Acupuncture Stimuli at ZUSANLI(ST36) on Pulse Spectrum Variations

199 participants · First posted Jun 28, 2022

Drugs

DMPK SNP-2 (WaVe Life Sciences)

CEP290 stereopure antisense oligonucleotide therapy (Wave Life Sciences)

SERPINA1 stereopure nucleic acid therapeutic(WaVe Life Sciences)

Organizations

NEWAVE PHARMACEUTICAL INC.

United States

NextWave Pharmaceuticals, Inc.

United States

WHOLESOME WAVE

United States

News

View all 67 →

Nxera Pharma Achieves Key Development Milestone in Eli Lilly Collaboration for Diabetes and Metabolic Disease Treatments

Nxera and Cancer Research UK Presenting Phase 1/2a Trial of EP4 Antagonist HTL0039732 at ESMO 2024

FDA Clears IND for Neurocrine and Nxera's Oral M1 Agonist NBI-1117567 in Alzheimer's Cognition

Page 1 of 88